The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.